StockTipsArenaBeta

Neuland Laboratories Share price target & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹18,935-40.00 (-0.21%)
As of 22 Oct 2026

Only one active 1-year target

The long-term call is BUY

₹25,81936.4% above today's price

Neuland Laboratories has one active 1-year share price target: ₹25,819 from JM Financial (6 Aug 2026). One target is a single view, not a consensus.

1
1 BUY · 0 SELL, all horizons
1
with an active 1Y target
N/A
4 of 10 closed calls needed
5
all horizons, open and closed
Watch NEULANDLAB for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

All tips (5)

BUYTarget₹25,819
JFbyJM Financial+36.4% to target
1 Year* · 10 mo left · 6 Aug 2026 · entry ₹21,348 · via CNBC TV18 MarketP&L -11.3%
BUYTarget₹23,300
GSbyGoldman SachsTarget hit
1 Year* · 6 Aug 2026 · entry ₹21,800 · via ET Now (Live)exit ₹23,300
BUYTarget₹21,120
NVbyNirav Vora, JM FinancialTarget hit
1 Year · 14 May 2026 · entry ₹16,630 · via ET Nowexit ₹21,120
BUYTarget₹18,000
SMbySomil Mehta, SharekhanTarget hit
1–2 Weeks* · 18 Jun 2026 · entry ₹17,231 · via CNBC Awaaz.exit ₹18,000
BUYTarget₹20,600
VSbyVikas Sethi, Sethi FinmartStop-loss hit
Intraday · 15 Oct 2026 · entry ₹20,350 · via Zee Business (Live)exit ₹20,050

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks